GlaxoSmithKline PLC's short-term approach for consumer health is less is more with planned sales of two UK brands, but the long-term is all about more as it anticipates buying out Novartis AG's interest in the two companies' OTC drug and nutritional products joint venture.
With its fiscal 2017 second-quarter earnings report on July 26, the UK firm made clear it's ready to become sole...



